BRNS
Price
$0.97
Change
-$0.08 (-7.62%)
Updated
Mar 31 closing price
Capitalization
42.36M
37 days until earnings call
NEUP
Price
$5.76
Change
+$0.04 (+0.70%)
Updated
Mar 31 closing price
Capitalization
19.49M
Ad is loading...

BRNS vs NEUP

Header iconBRNS vs NEUP Comparison
Open Charts BRNS vs NEUPBanner chart's image
Barinthus Biotherapeutics
Price$0.97
Change-$0.08 (-7.62%)
Volume$10.16K
Capitalization42.36M
Neuphoria Therapeutics
Price$5.76
Change+$0.04 (+0.70%)
Volume$37.48K
Capitalization19.49M
BRNS vs NEUP Comparison Chart
Loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRNS vs. NEUP commentary
Apr 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a StrongBuy and NEUP is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 01, 2025
Stock price -- (BRNS: $0.97 vs. NEUP: $5.76)
Brand notoriety: BRNS and NEUP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 38% vs. NEUP: 21%
Market capitalization -- BRNS: $42.36M vs. NEUP: $19.49M
BRNS [@Biotechnology] is valued at $42.36M. NEUP’s [@Biotechnology] market capitalization is $19.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green whileNEUP’s FA Score has 1 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • NEUP’s FA Score: 1 green, 4 red.
According to our system of comparison, NEUP is a better buy in the long-term than BRNS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 6 TA indicator(s) are bullish while NEUP’s TA Score has 4 bullish TA indicator(s).

  • BRNS’s TA Score: 6 bullish, 3 bearish.
  • NEUP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BRNS is a better buy in the short-term than NEUP.

Price Growth

BRNS (@Biotechnology) experienced а -5.56% price change this week, while NEUP (@Biotechnology) price change was +6.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.59%. For the same industry, the average monthly price growth was -10.76%, and the average quarterly price growth was -10.15%.

Reported Earning Dates

BRNS is expected to report earnings on May 08, 2025.

NEUP is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-8.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRNS($42.4M) has a higher market cap than NEUP($19.5M). NEUP YTD gains are higher at: 67.930 vs. BRNS (-19.478). NEUP has higher annual earnings (EBITDA): -14.17M vs. BRNS (-52.89M). BRNS has more cash in the bank: 106M vs. NEUP (4.35M). NEUP has less debt than BRNS: NEUP (199K) vs BRNS (12.7M). BRNS has higher revenues than NEUP: BRNS (15M) vs NEUP (663K).
BRNSNEUPBRNS / NEUP
Capitalization42.4M19.5M217%
EBITDA-52.89M-14.17M373%
Gain YTD-19.47867.930-29%
P/E RatioN/A0.53-
Revenue15M663K2,262%
Total Cash106M4.35M2,440%
Total Debt12.7M199K6,382%
TECHNICAL ANALYSIS
Technical Analysis
BRNSNEUP
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 27 days ago
78%
Bullish Trend 6 days ago
87%
Declines
ODDS (%)
Bearish Trend 14 days ago
86%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYV130.585.55
+4.44%
Live Nation Entertainment
TILE19.840.09
+0.46%
Interface
BDC100.25-0.64
-0.63%
Belden
AMS2.78-0.03
-1.07%
American Shared Hospital Services
YMAB4.43-0.38
-7.90%
Y-mAbs Therapeutics

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with SLNO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
-7.36%
SLNO - BRNS
56%
Loosely correlated
-0.75%
NGNE - BRNS
51%
Loosely correlated
-19.35%
NEUP - BRNS
50%
Loosely correlated
+0.70%
IMVT - BRNS
48%
Loosely correlated
-6.97%
TARA - BRNS
35%
Loosely correlated
-6.99%
More

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with SYBX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then SYBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
+0.70%
SYBX - NEUP
64%
Loosely correlated
-3.12%
BRNS - NEUP
50%
Loosely correlated
-7.36%
ENSC - NEUP
31%
Poorly correlated
-21.23%
CMND - NEUP
30%
Poorly correlated
-3.27%
ZVSA - NEUP
27%
Poorly correlated
+3.35%
More